Atlas Trials

Comparative Bioavailability Study of Tablet and Granule Formulations of ADC189 and the Study of Ultra-high Dose

Clinical trial NCT06428903 · COMPLETED

Trial details

NCT number
NCT06428903
Sponsor
Jiaxing AnDiCon Biotech Co.,Ltd
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy Volunteer
Start date
2024-03-12
Primary completion
2024-09-22
Enrollment
48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.